Reading time: 3 minutes Tala Tayoun Antitumor antibody-drug conjugates (ADCs) are a class of therapeutic molecules used in cancer therapy. Their main purpose is to channel the drug to a specific tumor site, kill cancer cells while sparing healthy cells and minimizing collateral damage [1]. ADC comprises of three key components: (1) an antibody, (2)... Continue Reading →
Reading time: 4 minutes Mallory Kane The immune system is the first line of defense in detecting and destroying cancer cells. Several mechanisms are in place to prevent and slow cancer growth. However, cancerous cells often can avoid destruction by the immune system. These cells may contain genetic mutations that make them invisible to immune... Continue Reading →
Reading time: 5 minutes Colette Bilynsky New treatment strategies are almost constantly being tested in pre-clinical research and clinical trials, with many of them outlined in various OncoBites articles. This is incredibly important work as groundbreaking treatment strategies like CAR-T therapy have the capacity to radically improve patient outcomes. CAR-T therapy takes the patient's own... Continue Reading →
Reading time: 6 minutes Anthony Tao Bacteria are not often given the respect they sometimes deserve. People tend to consider them as foreign harbingers of plagues, colds, and rashes ‒ unwanted invaders that our immune systems are uniquely tasked to deport. Of course, it is very well accepted now that many of these microbes indeed... Continue Reading →
OncoBites 